Source - RNS
RNS Number : 6128G
Futura Medical PLC
31 May 2017
 


31 May 2017

 

 

 

Futura Medical plc

("Futura" or "the Company")

 

Total Voting Rights

 

As at the date of this announcement, the Company's issued share capital consists of 120,658,682 ordinary shares with a nominal value of 0.2 pence each ("Ordinary Shares"), each carrying one voting right.

The Company does not hold any Ordinary Shares in Treasury. Therefore, the total number of voting rights is 120,658,682.

The above figure of 120,658,682 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

For further information please contact:

 

Futura Medical plc

 

James Barder, Chief Executive

Tel: +44 (0) 1483 685 670

Email to: [email protected]

www.futuramedical.com

 

N+1 Singer (Nominated Adviser and Broker)

 

Aubrey Powell / Liz Yong

Corporate Finance

 

Tel:+44 (0) 20 7496 3000

For media enquiries please contact:

 

Buchanan

 

Mark Court / Sophie Cowles / Stephanie Watson

Tel: +44 (0) 20 7466 5000

 

 

Notes to Editors

 

Futura Medical plc

 

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

 

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

 

www.futuramedical.com


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRGMGFKVGRGNZM